Professor, University of South Australia
| Role | Organisation | Sources |
|---|---|---|
| Professor | University of South Australia | @AuManufacturing, Brandon Capital portfolio, Brandon BioCatalyst portfolio, Startup Daily |
| Co-founder and CSO | Cincera Therapeutics | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
| Chief Scientific Officer · Founder | Ankere Therapeutics | @AuManufacturing, Brandon Capital portfolio, Brandon BioCatalyst portfolio, Startup Daily |
| Biologist | Centre for Cancer Biology | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Stories naming Professor Stuart Pitson. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of Australian manufacturing items: Manildra draws on CEFC money to quit coal, Ankere Therapeutics launches with seed backing, Micro-X gear reaches Ukraine, plus a vessel naming, precinct tenders, an FFI appointment and a cable rebrand.
Biotech startup Ankere Therapeutics launches with a $10 million seed round co-led by IP Group and Brandon Capital to develop inflammatory lung disease therapies, building on research from Monash and UniSA scientists.
Also Brandon Capital portfolio·Startup Daily·@AuManufacturing
Cincera Therapeutics has received a million-dollar Biomedical Translation Bridge grant to advance its Des-1 inhibitor drug for obesity-related metabolic diseases. The Monash and UniSA spin-out previously secured venture funding from the Medical Research Commercialisation Fund.